Le site web n’est pas disponible en français dans son intégralité. Son contenu est international et peut aller à l’encontre des règlementations locales.

Transfection Cell Database - Detailed View


Cell Line: UKF-NB3

Cell Line Species/Tissue: Human / neuroblastoma 
Transfection Reagent: RNAiFect 
Nucleic Acid:
siRNA (dsRNA) 
Growth Medium:
Iscove‘s modified Dulbecco‘s medium (IMDM; Seromed) supplemented with 10% FCS, 100 IU/ml penicillin, and 100 j.tg/mi streptomycin at 37 °C in a humidified 5% CO2 incubator.  
Percent Serum (%):
5% FCS 
Reporter System:
 
Plasmid Purification Method:
 
Plate Format:
no information 
Number of Cells:
 
Percent Confluence(%):
70-80% 
Amount of Nucleic Acid (µg):
7 nM 
Amount of Enhancer (µl):
 
Amount of Reagent (µl):
no information 
Complex Incubation on Cells (hrs):
 
Analysis Performed Post-Transfection (hrs):
48 h 
Transfection Efficiency (%):
 
Knockdown Efficiency (%): no information  
 
Any modifications to the protocol?:
 
Notes:
siRNA was constructed directed against two different regions of ST8SiaIV (PST 1+11). PST 1: 5‘ GGCUGGCUCUUCAAUCUUtt 3‘ and 5‘ GAA GAUUGAAGAGCCAGCCt 3‘; PST II: 5‘ GGUUGGAAAAUCAAUUCCUtt 3‘ and 5‘ AGGAAUUGAUUUUCCAACCtt 3‘. siRNA/RNAiFect ratio of 1:6 To analyze the adhesion capacity of transfected cells, cells were collected 48 h later, and 0.5x 106 NB cells were then added to the HUVEC rnonolayer for 60 min.  
References:
ELSEVIER International Immunopharmacology 5 (2005) 757—769 Valproic acid modulates NCAM polysialylation and polysialyltransferase mRNA expression in human tumor cells Wolf-Dietrich Beecken, Tobias Engl, Henry Ogbomo, Boma Reija, Jindrich Cinatl, Jürgen Bereiter-Hahn, Elsie Oppermann, Dietger Jonas, Roman A. Blaheta*